Plasma derived from human umbilical cord blood modulates mitogen-induced proliferation of mononuclear cells isolated from the peripheral blood of ALS patients

Cell Transplantation

Volumn 25, Issue 5, 2016, Pages 963-971

  Eve, David J ^a   Ehrhart, Jared ^b   Zesiewicz, Theresa ^a   Jahan, Israt ^a   Kuzmin Nichols, Nicole ^b   Sanberg, Cyndy Davis ^b   Gooch, Clifton ^a   Sanberg, Paul R ^a   Garbuzova Davis, Svitlana ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b Saneron CCEL Therapeutics Inc   (United States)

Author keywords

Autoimmunity; Caspase; Human umbilical cord blood plasma (hUCBP); Nonresponders; Phytohemagglutinin

Indexed keywords

CASPASE 3; CASPASE 7; MITOGENIC AGENT; PHYTOHEMAGGLUTININ; CYTOKINE;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; AMYOTROPHIC LATERAL SCLEROSIS FUNCTIONAL RATING SCALE; AMYOTROPHIC LATERAL SCLEROSIS FUNCTIONAL RATING SCALE REVISED; APOPTOSIS; ARTICLE; CELL ISOLATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; ENZYME ACTIVITY; FEMALE; GROUPS BY AGE; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RATING SCALE; UMBILICAL CORD BLOOD; BIOSYNTHESIS; BLOOD; CELL CULTURE; CYTOLOGY; FETUS BLOOD; LEUKOCYTE; METABOLISM; MIDDLE AGED; PHYSIOLOGY;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; APOPTOSIS; CASPASE 3; CASPASE 7; CELLS, CULTURED; CYTOKINES; FEMALE; FETAL BLOOD; HUMANS; LEUKOCYTES; MALE; MIDDLE AGED; MITOGENS; PHYTOHEMAGGLUTININS;

EID: 84964290912     PISSN: 09636897     EISSN: 15553892     Source Type: Journal    
DOI: 10.3727/096368915X688579     Document Type: Article

References (40)

1. Alexianu, M. E. The role of immune processes in amyotrophic lateral sclerosis pathogenesis. Rom. J. Neurol. Psychiatry 33(3-4):215-227; 1995.
2. Andersen, P. M. Amyotrophic lateral sclerosis associated with mutations in the CuZn superoxide dismutase gene. Curr. Neurol. Neurosci. Rep. 6(1):37-46; 2006.
3. Appel, S. H.; Smith, R. G.; Alexianu, M. F.; Engelhardt, J. I.; Stefani, E. Autoimmunity as an etiological factor in sporadic amyotrophic lateral sclerosis. Adv. Neurol. 68:47-57; 1995.
4. Baba, K.; Yamazaki, Y.; Ikemoto, S.; Aoyagi, K.; Takeda, A.; Uchinuma, E. Osteogenic potential of human umbilical cord-derived mesenchymal stromal cells cultured with umbilical cord blood-derived autoserum. J. Craniomaxillofac. Surg. 40(8):768-772; 2012.
5. Banerjee, R.; Mosley, R. L.; Reynolds, A. D.; Dhar, A.; Jackson-Lewis, V.; Gordon, P. H.; Przedborski, S.; Gendelman, H. E. Adaptive immune neuroprotection in G93A-SOD1 amyotrophic lateral sclerosis mice. PLoS One 3(7):e2740; 2008.
6. Beers, D. R.; Henkel, J. S.; Zhao, W.; Wang, J.; Appel, S. H. CD4+ T cells support glial neuroprotection, slow disease progression, and modify glial morphology in an animal model of inherited ALS. Proc. Natl. Acad. Sci. USA 105(40):15558-15563; 2008.
7. Bossolasco, P.; Cova, L.; Calzarossa, C.; Servida, F.; Mencacci, N. E.; Onida, F.; Polli, E.; Lambertenghi Deliliers, G.; Silani, V. Metalloproteinase alterations in the bone marrow of ALS patients. J. Mol. Med. 88(6):553-564; 2010.
8. Broxmeyer, H. E.; Benninger, L.; Yip-Schneider, M.; Braun, S. E. Commentary: A rapid proliferation assay for unknown co-stimulating factors in cord blood plasma possibly involved in enhancement of in vitro expansion and replating capacity of human hematopoietic stem/progenitor cells. Blood Cells 20(2-3):492-497; 1994.
9. Chiu, I. M.; Chen, A.; Zheng, Y.; Kosaras, B.; Tsiftsoglou, S. A.; Vartanian, T. K.; Brown, Jr., R. H.; Carroll, M. C. T lymphocytes potentiate endogenous neuroprotective inflammation in a mouse model of ALS. Proc. Natl. Acad. Sci. USA 105(46):17913-17918; 2008.
10. Coban, A.; Ulusoy, C.; Giris, M.; Turan, S.; Turkoglu, R.; Tuzun, E.; Idrisoglu, H. A. Serum anti-neuronal antibodies in amyotrophic lateral sclerosis. Int. J. Neurosci. 123(8):557-562; 2013.
11. Ding, Y.; Yang, H.; Feng, J. B.; Qiu, Y.; Li, D. S.; Zeng, Y. Human umbilical cord-derived MSC culture: The replacement of animal sera with human cord blood plasma. In Vitro Cell. Dev. Biol. Anim. 49(10):771-777; 2013.
12. Ferrero, I.; Mazzini, L.; Rustichelli, D.; Gunetti, M.; Mareschi, K.; Testa, L.; Nasuelli, N.; Oggioni, G. D.; Fagioli, F. Bone marrow mesenchymal stem cells from healthy donors and sporadic amyotrophic lateral sclerosis patients. Cell Transplant. 17(3):255-266; 2008.
13. Fiala, M.; Chattopadhay, M.; La Cava, A.; Tse, E.; Liu, G.; Lourenco, E.; Eskin, A.; Liu, P. T.; Magpantay, L.; Tse, S.; Mahanian, M.; Weitzman, R.; Tong, J.; Nguyen, C.; Cho, T.; Koo, P.; Sayre, J.; Martinez-Maza, O.; Rosenthal, M. J.; Wiedau-Pazos, M. IL-17A is increased in the serum and in spinal cord CD8 and mast cells of ALS patients. J. Neuroinflammation 7:76; 2010.
14. Fiszman, M. L.; Borodinsky, L. N.; Ricart, K. C.; Sanz, O. P.; Sica, R. E. Cu/Zn superoxide dismutase activity at different ages in sporadic amyotrophic lateral sclerosis. J. Neurol. Sci. 162(1):34-37; 1999.
15. Garbuzova-Davis, S.; Rodrigues, M. C.; Mirtyl, S.; Turner, S.; Mitha, S.; Sodhi, J.; Suthakaran, S.; Eve, D. J.; Sanberg, C. D.; Kuzmin-Nichols, N.; Sanberg, P. R. Multiple intra-venous administrations of human umbilical cord blood cells benefit in a mouse model of ALS. PLoS One 7(2):e31254; 2012.
16. Garbuzova-Davis, S.; Sanberg, C. D.; Kuzmin-Nichols, N.; Willing, A. E.; Gemma, C.; Bickford, P. C.; Miller, C.; Rossi, R.; Sanberg, P. R. Human umbilical cord blood treat-ment in a mouse model of ALS: Optimization of cell dose. PLoS One 3(6):e2494; 2008.
17. Garbuzova-Davis, S.; Willing, A. E.; Zigova, T.; Saporta, S.; Justen, E. B.; Lane, J. C.; Hudson, J. E.; Chen, N.; Davis, C. D.; Sanberg, P. R. Intravenous administration of human umbilical cord blood cells in a mouse model of amyotrophic lateral sclerosis: Distribution, migration, and differentiation. J. Hematother. Stem Cell Res. 12(3):255-270; 2003.
18. Huang, L.; Critser, P. J.; Grimes, B. R.; Yoder, M. C. Human umbilical cord blood plasma can replace fetal bovine serum for in vitro expansion of functional human endothelial colony-forming cells. Cytotherapy 13(6):712-721; 2011.
19. Kang, S. H.; Li, Y.; Fukaya, M.; Lorenzini, I.; Cleveland, D. W.; Ostrow, L. W.; Rothstein, J. D.; Bergles, D. E. Degeneration and impaired regeneration of gray matter oligodendrocytes in amyotrophic lateral sclerosis. Nat. Neurosci. 16(5):571-579; 2013.
20. Kim, H. Y.; Kim, H.; Oh, K. W.; Oh, S. I.; Koh, S. H.; Baik, W.; Noh, M. Y.; Kim, K. S.; Kim, S. H. Biological markers of mesenchymal stromal cells as predictors of response to autologous stem cell transplantation in patients with amyotrophic lateral sclerosis: An investigator-initiated trial and in vivo study. Stem Cells 32(10):2724-2731; 2014.
21. Kim, Y. M.; Jung, M. H.; Song, H. Y.; Yang, H. O.; Lee, S. T.; Kim, J. H.; Kim, Y. T.; Nam, J. H.; Mok, J. E. Ex vivo expansion of human umbilical cord blood-derived T-lymphocytes with homologous cord blood plasma. Tohoku J. Exp. Med. 205(2):115-122; 2005.
22. Kuzmenok, O. I.; Sanberg, P. R.; Desjarlais, T. G.; Bennett, S. P.; Garbuzova-Davis, S. N. Lymphopenia and spontaneous autorosette formation in SOD1 mouse model of ALS. J. Neuroimmunol. 172(1-2):132-136; 2006.
23. Lam, A. C.; Li, K.; Zhang, X. B.; Li, C. K.; Fok, T. F.; Chang, A. M.; James, A. E.; Tsang, K. S.; Yuen, P. M. Preclinical ex vivo expansion of cord blood hematopoietic stem and progenitor cells: Duration of culture; the media, serum supplements, and growth factors used; and engraft-ment in NOD/SCID mice. Transfusion 41(12):1567-1576; 2001.
24. Lee, J. Y.; Nam, H.; Park, Y. J.; Lee, S. J.; Chung, C. P.; Han, S. B.; Lee, G. The effects of platelet-rich plasma derived from human umbilical cord blood on the osteogenic dif-ferentiation of human dental stem cells. In Vitro Cell. Dev. Biol. Anim. 47(2):157-164; 2011.
25. Liu, Z.; Martin, L. J. The adult neural stem and progenitor cell niche is altered in amyotrophic lateral sclerosis mouse brain. J. Comp. Neurol. 497(3):468-488; 2006.
26. Mayani, H.; Lansdorp, P. M. Biology of human umbilical cord blood-derived hematopoietic stem/progenitor cells. Stem Cells 16(3):153-165; 1998.
27. Murdock, B. J.; Bender, D. E.; Segal, B. M.; Feldman, E. L. The dual roles of immunity in ALS: Injury overrides protection. Neurobiol. Dis. 77:1-12; 2015.
28. Niebroj-Dobosz, I.; Dziewulska, D.; Janik, P. Autoantibodies against proteins of spinal cord cells in cerebrospinal fluid of patients with amyotrophic lateral sclerosis (ALS). Folia Neuropathol. 44(3):191-196; 2006.
29. Pagani, M. R.; Gonzalez, L. E.; Uchitel, O. D. Autoimmunity in amyotrophic lateral sclerosis: Past and present. Neurol. Res. Int. 2011:497080; 2011.
30. Pramatarova, A.; Figlewicz, D. A.; Krizus, A.; Han, F. Y.; Ceballos-Picot, I.; Nicole, A.; Dib, M.; Meininger, V.; Brown, R. H.; Rouleau, G. A. Identification of new mutations in the Cu/Zn superoxide dismutase gene of patients with familial amyotrophic lateral sclerosis. Am. J. Hum. Genet. 56(3):592-596; 1995.
31. Provinciali, L.; Laurenzi, M. A.; Vesprini, L.; Giovagnoli, A. R.; Bartocci, C.; Montroni, M.; Bagnarelli, P.; Clementi, M.; Varaldo, P. E. Immunity assessment in the early stages of amyotrophic lateral sclerosis: A study of virus antibodies and lymphocyte subsets. Acta Neurol. Scand. 78(6):449-454; 1988.
32. Rentzos, M.; Rombos, A.; Nikolaou, C.; Zoga, M.; Zouvelou, V.; Dimitrakopoulos, A.; Alexakis, T.; Tsoutsou, A.; Samakovli, A.; Michalopoulou, M.; Evdokimidis, J. Interleukin-17 and interleukin-23 are elevated in serum and cerebrospinal fluid of patients with ALS: A reflection of Th17 cells activation? Acta Neurol. Scand. 122(6):425-429; 2010.
33. Rodrigues, M. C.; Sanberg, P. R.; Cruz, L. E.; Garbuzova-Davis, S. The innate and adaptive immunological aspects in neurodegenerative diseases. J. Neuroimmunol. 269(1-2): 1-8; 2014.
34. Rowland, L. P.; Shneider, N. A. Amyotrophic lateral sclerosis. N. Engl. J. Med. 344(22):1688-1700; 2001.
35. Saresella, M.; Piancone, F.; Tortorella, P.; Marventano, I.; Gatti, A.; Caputo, D.; Lunetta, C.; Corbo, M.; Rovaris, M.; Clerici, M. T helper-17 activation dominates the immunologic milieu of both amyotrophic lateral sclerosis and progressive multiple sclerosis. Clin. Immunol. 148(1):79-88; 2013.
36. Schwartz, M.; Baruch, K. Breaking peripheral immune tolerance to CNS antigens in neurodegenerative diseases: Boosting autoimmunity to fight-off chronic neuroinflam-mation. J. Autoimmun. 54:8-14; 2014.
37. Todaro, A. M.; Pafumi, C.; Pernicone, G.; Munda, S.; Pilastro, M. R.; Russo, A.; Farina, M.; Messina, A. Haematopoietic progenitors from umbilical cord blood. Blood Purif. 18(2):144-147; 2000.
38. Vajpayee, R. B.; Mukerji, N.; Tandon, R.; Sharma, N.; Pandey, R. M.; Biswas, N. R.; Malhotra, N.; Melki, S. A. Evaluation of umbilical cord serum therapy for persistent corneal epithelial defects. Br. J. Ophthalmol. 87(11):1312-1316; 2003.
39. Yoon, K. C.; Choi, W.; You, I. C.; Choi, J. Application of umbilical cord serum eyedrops for recurrent corneal erosions. Cornea 30(7):744-748; 2011.
40. Yoon, K. C.; You, I. C.; Im, S. K.; Jeong, T. S.; Park, Y. G.; Choi, J. Application of umbilical cord serum eyedrops for the treatment of neurotrophic keratitis. Ophthalmology 114(9):1637-1642; 2007